$2.49 Billion is the total value of Artal Group S.A.'s 109 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 34.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WW | New | WW INTL INC | $560,428,000 | – | 14,818,300 | +100.0% | 22.47% | – |
| LXRX | LEXICON PHARMACEUTICALS INC | $181,325,000 | -52.1% | 60,240,864 | 0.0% | 7.27% | -52.6% | |
| BMY | Buy | BRISTOL MYERS SQUIBB COcall | $177,485,000 | +73.9% | 3,500,000 | +55.6% | 7.12% | +72.4% |
| AVTR | Sell | AVANTOR INC | $88,200,000 | -34.0% | 6,000,000 | -14.3% | 3.54% | -34.6% |
| BAC | New | BANK AMER CORPcall | $87,510,000 | – | 3,000,000 | +100.0% | 3.51% | – |
| BGNE | BEIGENE LTDsponsored adr | $79,599,000 | -1.2% | 650,000 | 0.0% | 3.19% | -2.1% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $75,254,000 | -1.3% | 450,000 | 0.0% | 3.02% | -2.2% | |
| MRNA | MODERNA INC | $73,332,000 | +8.7% | 4,606,298 | 0.0% | 2.94% | +7.8% | |
| MDCO | Buy | MEDICINES CO | $70,000,000 | +91.9% | 1,400,000 | +40.0% | 2.81% | +90.3% |
| MS | New | MORGAN STANLEYcall | $64,005,000 | – | 1,500,000 | +100.0% | 2.57% | – |
| XLRN | ACCELERON PHARMA INC | $59,265,000 | -3.8% | 1,500,000 | 0.0% | 2.38% | -4.7% | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $56,294,000 | +94.0% | 700,000 | +75.0% | 2.26% | +92.2% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $44,082,000 | -37.7% | 600,000 | -20.0% | 1.77% | -38.2% |
| NVDA | Sell | NVIDIA CORP | $34,814,000 | -49.5% | 200,000 | -52.4% | 1.40% | -50.0% |
| MORF | Buy | MORPHIC HLDG INC | $32,945,000 | +232.4% | 1,819,186 | +263.8% | 1.32% | +229.4% |
| FATE | Buy | FATE THERAPEUTICS INC | $31,060,000 | +2.0% | 2,000,000 | +33.3% | 1.24% | +1.1% |
| GOSS | GOSSAMER BIO INC | $27,015,000 | -24.3% | 1,608,968 | 0.0% | 1.08% | -24.9% | |
| ARGX | Sell | ARGENX SEsponsored adr | $22,792,000 | -26.8% | 200,000 | -9.1% | 0.91% | -27.5% |
| RUBY | RUBIUS THERAPEUTICS INC | $22,246,000 | -50.1% | 2,833,791 | 0.0% | 0.89% | -50.5% | |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $21,180,000 | -8.4% | 1,500,000 | +30.4% | 0.85% | -9.2% |
| SAGE | SAGE THERAPEUTICS INC | $21,044,000 | -23.4% | 150,000 | 0.0% | 0.84% | -24.0% | |
| SRRK | SCHOLAR ROCK HLDG CORP | $20,997,000 | -43.6% | 2,346,040 | 0.0% | 0.84% | -44.1% | |
| FOLD | AMICUS THERAPEUTICS INC | $20,050,000 | -35.7% | 2,500,000 | 0.0% | 0.80% | -36.3% | |
| Z | Sell | ZILLOW GROUP INCcl c cap stk | $19,383,000 | -58.2% | 650,000 | -35.0% | 0.78% | -58.6% |
| XBI | New | SPDR SERIES TRUSTcall | $19,063,000 | – | 250,000 | +100.0% | 0.76% | – |
| INCY | INCYTE CORPcall | $18,558,000 | -12.6% | 250,000 | 0.0% | 0.74% | -13.4% | |
| SLDB | Buy | SOLID BIOSCIENCES INC | $17,578,000 | +154.8% | 1,700,000 | +41.7% | 0.70% | +152.7% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $16,982,000 | – | 350,000 | +100.0% | 0.68% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $16,970,000 | – | 500,000 | +100.0% | 0.68% | – |
| BABA | Sell | ALIBABA GROUP HLDG LTDcall | $16,723,000 | -50.7% | 100,000 | -50.0% | 0.67% | -51.1% |
| CYCN | CYCLERION THERAPEUTICS INC | $16,502,000 | +5.8% | 1,361,584 | 0.0% | 0.66% | +4.9% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $15,582,000 | +0.9% | 200,000 | +33.3% | 0.62% | 0.0% |
| EPZM | Sell | EPIZYME INC | $15,473,000 | -25.3% | 1,500,000 | -9.1% | 0.62% | -26.0% |
| UBER | UBER TECHNOLOGIES INC | $15,235,000 | -34.3% | 500,000 | 0.0% | 0.61% | -34.9% | |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $15,040,000 | +84.8% | 400,000 | +100.0% | 0.60% | +83.3% |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $14,448,000 | -16.4% | 150,000 | 0.0% | 0.58% | -17.2% | |
| DRNA | DICERNA PHARMACEUTICALS INC | $14,360,000 | -8.8% | 1,000,000 | 0.0% | 0.58% | -9.6% | |
| AAL | AMERICAN AIRLS GROUP INCcall | $13,485,000 | -17.3% | 500,000 | 0.0% | 0.54% | -17.9% | |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $12,960,000 | -48.0% | 400,000 | -20.0% | 0.52% | -48.5% |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $12,740,000 | -25.8% | 700,000 | 0.0% | 0.51% | -26.4% | |
| REAL | Buy | THE REALREAL INC | $12,633,000 | +2085.6% | 565,000 | +2725.0% | 0.51% | +2104.3% |
| TCDA | TRICIDA INC | $11,113,000 | -21.8% | 360,000 | 0.0% | 0.45% | -22.4% | |
| NKTR | Buy | NEKTAR THERAPEUTICScall | $10,929,000 | +207.2% | 600,000 | +500.0% | 0.44% | +204.2% |
| YMAB | Y MABS THERAPEUTICS INC | $10,424,000 | +13.9% | 400,000 | 0.0% | 0.42% | +13.0% | |
| STNE | STONECO LTD | $10,434,000 | +17.6% | 300,000 | 0.0% | 0.42% | +16.4% | |
| XNCR | Buy | XENCOR INC | $10,119,000 | -10.1% | 300,000 | +9.1% | 0.41% | -10.8% |
| DLPH | New | DELPHI TECHNOLOGIES PLCcall | $10,050,000 | – | 750,000 | +100.0% | 0.40% | – |
| FIS | New | FIDELITY NATL INFORMATION SV | $9,957,000 | – | 75,000 | +100.0% | 0.40% | – |
| BOLD | AUDENTES THERAPEUTICS INC | $9,832,000 | -25.8% | 350,000 | 0.0% | 0.39% | -26.5% | |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INC | $9,285,000 | -9.8% | 500,000 | +11.1% | 0.37% | -10.6% |
| BLUE | BLUEBIRD BIO INC | $9,182,000 | -27.8% | 100,000 | 0.0% | 0.37% | -28.4% | |
| NKTR | Sell | NEKTAR THERAPEUTICS | $9,108,000 | -63.4% | 500,000 | -28.6% | 0.36% | -63.8% |
| ALBO | Buy | ALBIREO PHARMA INC | $9,004,000 | -37.9% | 450,200 | +0.0% | 0.36% | -38.5% |
| MRUS | Buy | MERUS N V | $8,910,000 | +73.8% | 500,000 | +42.9% | 0.36% | +72.5% |
| HOOK | HOOKIPA PHARMA INC | $8,510,000 | +11.4% | 1,134,616 | 0.0% | 0.34% | +10.4% | |
| REPL | REPLIMUNE GROUP INC | $8,340,000 | -5.2% | 600,000 | 0.0% | 0.33% | -6.2% | |
| MRNA | MODERNA INCcall | $7,960,000 | +8.7% | 500,000 | 0.0% | 0.32% | +7.8% | |
| NERV | New | MINERVA NEUROSCIENCES INC | $7,750,000 | – | 1,000,000 | +100.0% | 0.31% | – |
| PRQR | PROQR THRAPEUTICS N V | $7,488,000 | -36.7% | 1,300,000 | 0.0% | 0.30% | -37.2% | |
| TBIO | TRANSLATE BIO INC | $7,433,000 | -21.5% | 750,000 | 0.0% | 0.30% | -22.2% | |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $7,092,000 | +1.1% | 471,846 | -3.7% | 0.28% | 0.0% |
| KLDO | KALEIDO BIOSCIENCES INC | $6,781,000 | -35.1% | 900,500 | 0.0% | 0.27% | -35.5% | |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $6,689,000 | – | 308,526 | +100.0% | 0.27% | – |
| FGEN | FIBROGEN INC | $6,656,000 | -18.2% | 180,000 | 0.0% | 0.27% | -18.8% | |
| AGEN | AGENUS INC | $6,450,000 | -14.0% | 2,500,000 | 0.0% | 0.26% | -14.5% | |
| AUTL | AUTOLUS THERAPEUTICS PLCsponsored ads | $6,210,000 | -22.9% | 500,000 | 0.0% | 0.25% | -23.6% | |
| DNLI | DENALI THERAPEUTICS INC | $6,128,000 | -26.2% | 400,000 | 0.0% | 0.25% | -26.8% | |
| ARQL | Buy | ARQULE INC | $6,095,000 | -20.9% | 850,000 | +21.4% | 0.24% | -21.8% |
| SPRO | SPERO THERAPEUTICS INC | $5,724,000 | -7.9% | 540,000 | 0.0% | 0.23% | -8.8% | |
| KRYS | Sell | KRYSTAL BIOTECH INC | $5,209,000 | -56.9% | 150,000 | -50.0% | 0.21% | -57.3% |
| RGNX | REGENXBIO INC | $5,162,000 | -30.7% | 145,000 | 0.0% | 0.21% | -31.2% | |
| TGTX | TG THERAPEUTICS INC | $5,054,000 | -35.1% | 900,000 | 0.0% | 0.20% | -35.6% | |
| ACIU | AC IMMUNE SA | $4,950,000 | -10.8% | 1,000,000 | 0.0% | 0.20% | -11.6% | |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $4,635,000 | -52.0% | 150,000 | -25.0% | 0.19% | -52.4% |
| LGFA | New | LIONS GATE ENTMNT CORPcall | $4,625,000 | – | 500,000 | +100.0% | 0.18% | – |
| TORC | Buy | RESTORBIO INC | $4,420,000 | +20.4% | 500,000 | +38.9% | 0.18% | +18.8% |
| BBIO | BRIDGEBIO PHARMA INC | $4,294,000 | -20.4% | 200,000 | 0.0% | 0.17% | -21.1% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $4,158,000 | -15.1% | 350,000 | 0.0% | 0.17% | -15.7% | |
| FOLD | New | AMICUS THERAPEUTICS INCcall | $4,010,000 | – | 500,000 | +100.0% | 0.16% | – |
| KURA | New | KURA ONCOLOGY INC | $3,793,000 | – | 250,000 | +100.0% | 0.15% | – |
| STML | STEMLINE THERAPEUTICS INC | $3,748,000 | -32.0% | 360,000 | 0.0% | 0.15% | -32.7% | |
| SELB | SELECTA BIOSCIENCES INC | $3,675,000 | -2.2% | 2,100,000 | 0.0% | 0.15% | -3.3% | |
| SGMO | SANGAMO THERAPEUTICS INC | $3,665,000 | -16.0% | 405,000 | 0.0% | 0.15% | -16.5% | |
| IGMS | New | IGM BIOSCIENCES INC | $3,550,000 | – | 200,000 | +100.0% | 0.14% | – |
| DOYU | New | DOUYU INTERNATIONAL HLDNGS Lsponsored ads | $3,276,000 | – | 400,000 | +100.0% | 0.13% | – |
| ALEC | ALECTOR INC | $3,245,000 | -24.1% | 225,000 | 0.0% | 0.13% | -24.9% | |
| YI | Buy | 111 INCads | $3,166,000 | +26.5% | 650,000 | +44.4% | 0.13% | +25.7% |
| NIO | Sell | NIO INCsponsored ads | $3,120,000 | -74.8% | 2,000,000 | -58.8% | 0.12% | -75.0% |
| ARAV | Buy | ARAVIVE INC | $3,000,000 | +62.6% | 400,000 | +30.1% | 0.12% | +60.0% |
| NIO | NIO INCcall | $2,730,000 | -38.8% | 1,750,000 | 0.0% | 0.11% | -39.8% | |
| ALLO | Sell | ALLOGENE THERAPEUTICS INC | $2,726,000 | -49.2% | 100,000 | -50.0% | 0.11% | -49.8% |
| AXLA | Buy | AXCELLA HEALTH INC | $2,547,000 | -29.8% | 450,000 | +15.5% | 0.10% | -30.6% |
| VKTX | Buy | VIKING THERAPEUTICS INC | $2,408,000 | +190.1% | 350,000 | +250.0% | 0.10% | +185.3% |
| TWST | TWIST BIOSCIENCE CORP | $2,388,000 | -17.7% | 100,000 | 0.0% | 0.10% | -17.9% | |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $2,307,000 | +99.4% | 300,000 | +77.6% | 0.09% | +95.7% |
| GRTS | Sell | GRITSTONE ONCOLOGY INC | $2,159,000 | -61.2% | 250,000 | -50.0% | 0.09% | -61.3% |
| CLVS | New | CLOVIS ONCOLOGY INC | $1,965,000 | – | 500,000 | +100.0% | 0.08% | – |
| SQ | New | SQUARE INCcl a | $1,859,000 | – | 30,000 | +100.0% | 0.08% | – |
| AKBA | AKEBIA THERAPEUTICS INC | $1,666,000 | -19.0% | 425,000 | 0.0% | 0.07% | -19.3% | |
| ADRO | ADURO BIOTECH INC | $1,060,000 | -31.2% | 1,000,000 | 0.0% | 0.04% | -32.3% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $949,000 | -21.5% | 110,532 | 0.0% | 0.04% | -22.4% | |
| AVRO | Sell | AVROBIO INC | $331,000 | -77.4% | 23,449 | -73.9% | 0.01% | -78.0% |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -23,524 | -100.0% | -0.01% | – |
| NGM | Exit | NGM BIOPHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.06% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -270,000 | -100.0% | -0.09% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -35,000 | -100.0% | -0.15% | – |
| FTDR | Exit | FRONTDOOR INC | $0 | – | -100,000 | -100.0% | -0.18% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -100,000 | -100.0% | -0.19% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.20% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -360,000 | -100.0% | -0.22% | – |
| CRWD | Exit | CROWDSTRIKE HLDGS INCcl a | $0 | – | -100,000 | -100.0% | -0.28% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -850,000 | -100.0% | -0.40% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -0.44% | – |
| CHNG | Exit | CHANGE HEALTHCARE INC | $0 | – | -750,000 | -100.0% | -0.44% | – |
| HTHT | Exit | HUAZHU GROUP LTDsponsored ads | $0 | – | -350,000 | -100.0% | -0.51% | – |
| NVDA | Exit | NVIDIA CORPcall | $0 | – | -100,000 | -100.0% | -0.66% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INCcall | $0 | – | -200,000 | -100.0% | -0.68% | – |
| MLCO | Exit | MELCO RESORTS AND ENTMT LTDcall | $0 | – | -1,000,000 | -100.0% | -0.88% | – |
| GM | Exit | GENERAL MTRS COcall | $0 | – | -1,000,000 | -100.0% | -1.56% | – |
| WW | Exit | WEIGHT WATCHERS INTL INC NEW | $0 | – | -14,818,300 | -100.0% | -11.45% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.